4 ms·
Well the generic market only works when pay for delay and other morally bankrupt acts don't happen: https://www.ftc.gov/news-events/media-resources/mergers-comp
by nimish 6y ago
Well the generic market only works when pay for delay and other morally bankrupt acts don't happen: https://www.ftc.gov/news-events/media-resources/mergers-competition/pay-delay https://www.ftc.gov/news-events/media-resources/mergers-comp...
and it basically doesn't work with biologics since biosimilars are far more difficult to make.
- refurb 6y agoI never understood why pay for delay deals are bad. It’s basically splitting the difference between two possible scenarios: Scenario 1: patent is valid, generic drug doesn’t launch for 2 years Scenario 2: patent is invalid and generic drug can launch immediately The only reason you see pay for delay deals is when neither scenario is certain. Otherwise, why do a deal? So they could only be called a “delay” if the patent is invalid. But if the patent was 100% invalid, the generic company wouldn’t negotiate a deal. Most of the time, pay for “delay” deals get the generic drug on market sooner.